P70 S6 kinase inhibitor and EGFR inhibitor combination therapy

Details for Australian Patent Application No. 2009314336 (hide)

Owner Eli Lilly and Company

Inventors Geeganage, Sandaruwan

Agent Spruson & Ferguson

Pub. Number AU-A-2009314336

PCT Pub. Number WO2010/056575

Priority 61/113,276 11.11.08 US

Filing date 4 November 2009

Wipo publication date 20 May 2010

International Classifications

A61K 31/436 (2006.01)

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/056575 Priority application(s): WO2010/056575

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009314345-Method of producing serum-free insulinfree Factor VII

2009314335-P70 S6 kinase inhibitor and mTOR inhibitor combination therapy